Income Statement Mitsuba Corporation

Stocks

7280

JP3895200008

Auto, Truck & Motorcycle Parts

Delayed Japan Exchange Other stock markets 02:30:00 2026-06-19 EDT			5-day change	1st Jan Change
1,117.00 ^JPY	-0.18%		+4.69%	+6.79%

05-15	Mitsuba To Partially Redeem Class D Shares In Phased Capital Return Plan	MT
05-15	Mitsuba Corporation Reports Earnings Results for the Full Year Ended March 31, 2026	CI

c.wK6SLtkUcgHFJCqMadNTVLJxNAYZSXg1XwBJyLWIX1Y.kt_df5BYCGLxEELrA4UdNe0fU0JQKDoYNWd4n9HYbDq3wPl6kEAEcvZIEg

Published financial data: MITSUBA CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	269B	286B	320B	344B	349B
Total Revenues	269B	286B	320B	344B	349B
Cost of Goods Sold, Total	231B	248B	279B	292B	295B
Gross Profit	38.05B	38.91B	40.04B	52.48B	54.29B
Selling General & Admin Expenses, Total	28.56B	31.47B	32.78B	30.7B	32.85B
Provision for Bad Debts	-	-	-	-	-225M
Other Operating Expenses	946M	252M	547M	621M	507M
Other Operating Expenses, Total	29.5B	31.72B	33.32B	31.32B	33.13B
Operating Income	8.55B	7.19B	6.72B	21.15B	21.16B
Interest Expense, Total	-1.96B	-1.94B	-2.13B	-2.36B	-2.36B
Interest And Investment Income	782M	958M	1.43B	2.12B	2.5B
Net Interest Expenses	-1.18B	-979M	-695M	-244M	141M
Income (Loss) On Equity Invest.	254M	69M	27M	446M	535M
Currency Exchange Gains (Loss)	967M	1.62B	746M	1.59B	-1.22B
Other Non Operating Income (Expenses)	156M	-372M	-750M	-599M	-596M
EBT, Excl. Unusual Items	8.75B	7.53B	6.05B	22.34B	20.01B
Gain (Loss) On Sale Of Investments	399M	1.01B	292M	1.15B	432M
Gain (Loss) On Sale Of Assets	36M	745M	106M	10M	19M
Asset Writedown	-534M	-326M	-471M	-521M	-1.8B
Legal Settlements	-210M	-	-	-	-
Other Unusual Items	-2.87B	-4.06B	-120M	-4.46B	-576M
EBT, Incl. Unusual Items	5.57B	4.9B	5.85B	18.52B	18.09B
Income Tax Expense	3.12B	3.08B	2.98B	2.86B	4.47B
Earnings From Continuing Operations	2.45B	1.81B	2.87B	15.66B	13.62B
Net Income to Company	2.45B	1.81B	2.87B	15.66B	13.62B
Minority Interest	-1.71B	-1.73B	-1.68B	-1.92B	-1.76B
Net Income - (IS)	732M	83M	1.18B	13.74B	11.86B
Preferred Dividend and Other Adjustments	-	-	-	600M	591M
Net Income to Common Incl Extra Items	732M	83M	1.18B	13.14B	11.27B
Net Income to Common Excl. Extra Items	732M	83M	1.18B	13.14B	11.27B
Per Share Items
Net EPS - Basic	16.36	1.85	26.48	293.62	251.88
Basic EPS - Continuing Operations	16.36	1.85	26.48	293.62	251.88
Basic Weighted Average Shares Outstanding	44.76M	44.76M	44.76M	44.76M	44.76M
Net EPS - Diluted	14.3	1.46	20.59	162.19	216.46
Diluted EPS - Continuing Operations	14.3	1.46	20.59	162.19	216.46
Diluted Weighted Average Shares Outstanding	51.18M	57.57M	57.57M	84.72M	54.81M
Normalized Basic EPS	83.87	66.44	46.82	269.15	240.21
Normalized Diluted EPS	73.34	51.65	36.4	142.18	196.14
Dividend Per Share	-	3	3	6	10
Payout Ratio	-	542.17	112.66	5.34	7.32
Supplemental Items
EBITDA	25.12B	23.69B	23.55B	37.33B	36.64B
EBITA	8.56B	7.2B	6.73B	21.15B	21.16B
EBIT	8.55B	7.19B	6.72B	21.15B	21.16B
Effective Tax Rate - (Ratio)	56.06	62.95	50.99	15.43	24.7
Normalized Net Income	3.75B	2.97B	2.1B	12.05B	10.75B
Non-Cash Pension Expense	-1.24B	-1.48B	-1.32B	-608M	-1.12B
Supplemental Operating Expense Items
Selling and Marketing Expenses	7.82B	9.33B	9.42B	6.78B	7.96B
Research And Development Expense From Footnotes	11.75B	13.32B	13.91B	14.94B	15.78B

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	78.75B	74.56B	75.79B	102B	97.91B
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	78.75B	74.56B	75.79B	102B	97.91B
Accounts Receivable, Total	50.74B	50.75B	50.66B	50.55B	47.14B
Total Receivables	50.74B	50.75B	50.66B	50.55B	47.14B
Inventory	55.07B	62.92B	59.42B	55.31B	50.55B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	18.19B	18.48B	12.31B	12.87B	15.04B
Total Current Assets	203B	207B	198B	221B	211B
Net Property Plant And Equipment	101B	99.38B	93.68B	94.29B	83.88B
Long-term Investments	32.32B	29.48B	28.63B	34.69B	32.04B
Other Intangibles, Total	3.56B	3.42B	3.68B	3.41B	3.11B
Loans Receivable Long-Term	2.35B	2.38B	2.5B	2.65B	2.53B
Deferred Tax Assets Long-Term	1.43B	1.38B	1.77B	1.47B	1.32B
Other Long-Term Assets, Total	1M	2M	2M	1M	1M
Total Assets	343B	343B	328B	357B	334B
Liabilities
Accounts Payable, Total	27.81B	25.38B	20.4B	21.61B	23.7B
Accrued Expenses, Total	6.01B	5.75B	6.61B	6.65B	7.31B
Short-term Borrowings	74.74B	56.71B	75.8B	114B	98.67B
Current Portion of Long-Term Debt	30M	30M	30M	15M	-
Current Portion of Leases	2.97B	3.28B	3.26B	2.93B	2.74B
Current Income Taxes Payable	18.16B	16.8B	18.35B	16.46B	13.72B
Other Current Liabilities	7.38B	7.49B	6.06B	6.73B	6.14B
Total Current Liabilities	137B	115B	131B	169B	152B
Long-Term Debt	113B	123B	94.59B	49.87B	52.88B
Long-Term Leases	5.6B	5.19B	5.18B	3.99B	6.02B
Pension & Other Post Retirement Benefits	2.16B	2.6B	2.91B	3.45B	3.5B
Deferred Tax Liability Non Current	7.97B	7.5B	7.43B	7.8B	6.92B
Other Non Current Liabilities	845M	952M	870M	1.23B	1.04B
Total Liabilities	267B	255B	241B	235B	223B
Common Stock, Total	5B	5B	5B	5B	5B
Additional Paid In Capital	33.93B	33.47B	26.37B	25.77B	14.13B
Retained Earnings	26.99B	27.2B	28.25B	45.24B	56.24B
Treasury Stock	-603M	-603M	-603M	-603M	-604M
Comprehensive Income and Other	-6.94B	2.96B	7.75B	26.23B	20.94B
Total Common Equity	58.37B	68.02B	66.77B	102B	95.7B
Minority Interest	17.84B	20.18B	20.19B	20.94B	15.19B
Total Equity	76.22B	88.2B	86.96B	123B	111B
Total Liabilities And Equity	343B	343B	328B	357B	334B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	44.76M	44.76M	44.76M	44.76M	45.91M
ECS Total Common Shares Outstanding	44.76M	44.76M	44.76M	44.76M	44.76M
Book Value / Share	1.3K	1.52K	1.49K	2.27K	2.14K
Tangible Book Value	54.81B	64.61B	63.08B	98.23B	92.58B
Tangible Book Value Per Share	1.22K	1.44K	1.41K	2.19K	2.07K
Total Debt	197B	188B	179B	171B	160B
Net Debt	118B	114B	103B	68.74B	62.4B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-9.27B	-8.74B	-7.67B	-10.55B	-10.28B
Minority Interest, Total (Incl. Fin. Div)	17.84B	20.18B	20.19B	20.94B	15.19B
Inventories - Raw Materials, Total	36.72B	43.07B	41.55B	38.36B	36.23B
Inventories - Work In Process, Total	5.4B	5.74B	5.72B	6.12B	4.64B
Inventories - Finished Goods, Total	12.95B	14.12B	12.15B	10.84B	9.68B
Full Time Employees	26.13K	24.34K	23.26K	22.66K	21.89K
Accumulated Allowance for Doubtful Accounts (Supple)	15M	17M	30M	34M	125M
Order Backlog	13.47B	11.59B	13.76B	14.83B	17.53B

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	5.57B	4.9B	5.86B	18.52B	18.09B
Depreciation & Amortization - CF	16.56B	16.49B	16.82B	16.18B	15.49B
Amortization of Goodwill and Intangible Assets - (CF)	13M	13M	13M	-	-
Depreciation & Amortization, Total	16.57B	16.5B	16.83B	16.18B	15.49B
(Gain) Loss From Sale Of Asset	499M	-418M	121M	512M	1.78B
(Gain) Loss on Sale of Investments - (CF)	-149M	-970M	-76M	-1.15B	-13M
(Income) Loss On Equity Investments - (CF)	-254M	-69M	-27M	-446M	-535M
Other Operating Activities, Total	-3.53B	-3.55B	-2.42B	-3.25B	-5.24B
Change In Accounts Receivable	-4.31B	4.86B	2.92B	5.3B	1.43B
Change In Inventories	-2.83B	-2.45B	6.05B	9.1B	3.68B
Change In Accounts Payable	4.58B	-7.38B	-8.3B	-6.76B	1.6B
Change in Other Net Operating Assets	-729M	567M	8.68B	3.5B	1.74B
Cash from Operations	15.41B	12B	29.62B	41.51B	38.02B
Capital Expenditure	-7.38B	-10.92B	-9.84B	-10.28B	-8.78B
Sale of Property, Plant, and Equipment	394M	1.8B	569M	200M	700M
Divestitures	-	-	-262M	-	1.17B
Sale (Purchase) of Intangible assets	-233M	-307M	-33M	-103M	-69M
Investment in Marketable and Equity Securities, Total	229M	2.11B	264M	5.01B	-36M
Net (Increase) Decrease in Loans Originated / Sold - Investing	154M	134M	164M	-92M	127M
Other Investing Activities, Total	180M	341M	-33M	21M	14M
Cash from Investing	-6.66B	-6.84B	-9.17B	-5.24B	-6.88B
Short Term Debt Issued, Total	-	1.33B	-	17.07B	-
Long-Term Debt Issued, Total	20.54B	15.24B	1.2B	2B	52.64B
Total Debt Issued	20.54B	16.57B	1.2B	19.07B	52.64B
Short Term Debt Repaid, Total	-2.36B	-	-821M	-	-20.7B
Long-Term Debt Repaid, Total	-22.83B	-26.48B	-10.9B	-27.2B	-44.85B
Total Debt Repaid	-25.19B	-26.48B	-11.72B	-27.2B	-65.55B
Issuance of Common Stock	19.93B	-	-	-	9.78B
Repurchase of Common Stock	-	-	-5.9B	-	-20.1B
Common Dividends Paid	-	-450M	-1.34B	-734M	-868M
Common & Preferred Stock Dividends Paid	-	-450M	-1.34B	-734M	-868M
Other Financing Activities, Total	-2.46B	-2.67B	-2.92B	-4.94B	-9.84B
Cash from Financing	12.82B	-13.02B	-20.68B	-13.79B	-33.92B
Foreign Exchange Rate Adjustments	2B	3.75B	1.26B	4.71B	-1.56B
Miscellaneous Cash Flow Adjustments	-	1M	-1M	-	-1M
Net Change in Cash	23.57B	-4.12B	1.03B	27.19B	-4.35B
Supplemental Items
Cash Interest Paid	1.99B	1.89B	2.12B	2.37B	2.39B
Cash Income Tax Paid (Refund)	2.33B	3.73B	2.54B	3.5B	5.4B
Levered Free Cash Flow	4.95B	-3.55B	15.59B	21.23B	23.81B
Unlevered Free Cash Flow	6.18B	-2.34B	16.92B	22.7B	25.29B
Change In Net Working Capital	8.12B	12.11B	-5.76B	-3.68B	-5.43B
Net Debt Issued / Repaid	-4.65B	-9.9B	-10.52B	-8.12B	-12.91B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	1.63	1.31	1.25	3.85	3.83
Return on Total Capital	2.07	1.64	1.55	4.73	4.68
Return On Equity %	4.06	2.21	3.28	14.95	11.67
Return on Common Equity	1.68	0.13	1.76	15.61	11.43
Margin Analysis
Gross Profit Margin %	14.14	13.58	12.53	15.25	15.54
SG&A Margin	10.61	10.98	10.26	8.92	9.4
EBITDA Margin %	9.33	8.27	7.37	10.85	10.49
EBITA Margin %	3.18	2.51	2.11	6.15	6.06
EBIT Margin %	3.18	2.51	2.1	6.15	6.06
Income From Continuing Operations Margin %	0.91	0.63	0.9	4.55	3.9
Net Income Margin %	0.27	0.03	0.37	3.99	3.4
Net Avail. For Common Margin %	0.27	0.03	0.37	3.82	3.23
Normalized Net Income Margin	1.39	1.04	0.66	3.5	3.08
Levered Free Cash Flow Margin	1.84	-1.24	4.88	6.17	6.82
Unlevered Free Cash Flow Margin	2.3	-0.82	5.3	6.6	7.24
Asset Turnover
Asset Turnover	0.82	0.84	0.95	1	1.01
Fixed Assets Turnover	2.59	2.86	3.31	3.66	3.92
Receivables Turnover (Average Receivables)	5.69	5.65	6.3	6.8	7.15
Inventory Turnover (Average Inventory)	4.41	4.2	4.57	5.08	5.57
Short Term Liquidity
Current Ratio	1.48	1.79	1.52	1.31	1.38
Quick Ratio	0.94	1.09	0.97	0.91	0.95
Operating Cash Flow to Current Liabilities	0.11	0.1	0.23	0.25	0.25
Days Sales Outstanding (Average Receivables)	64.15	64.65	57.93	53.82	51.04
Days Outstanding Inventory (Average Inventory)	82.78	86.98	79.89	71.98	65.48
Average Days Payable Outstanding	39.57	38	30.28	26.73	28.48
Cash Conversion Cycle (Average Days)	107.36	113.62	107.55	99.07	88.03
Long Term Solvency
Total Debt/Equity	257.9	213.25	205.69	139.49	144.58
Total Debt / Total Capital	72.06	68.08	67.29	58.24	59.11
LT Debt/Equity	155.9	145.19	114.73	43.94	53.12
Long-Term Debt / Total Capital	43.56	46.35	37.53	18.35	21.72
Total Liabilities / Total Assets	77.79	74.27	73.53	65.71	66.75
EBIT / Interest Expense	4.36	3.71	3.16	8.96	8.95
EBITDA / Interest Expense	12.81	12.23	11.08	15.81	15.51
(EBITDA - Capex) / Interest Expense	9.05	6.59	6.45	11.46	11.79
Total Debt / EBITDA	7.83	7.94	7.6	4.58	4.37
Net Debt / EBITDA	4.69	4.79	4.38	1.84	1.7
Total Debt / (EBITDA - Capex)	11.08	14.73	13.04	6.32	5.75
Net Debt / (EBITDA - Capex)	6.64	8.89	7.52	2.54	2.24
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-11.51	6.42	11.53	7.72	1.51
Gross Profit, 1 Yr. Growth %	-5.33	2.25	2.91	31.05	3.45
EBITDA, 1 Yr. Growth %	3.73	-5.67	-0.61	58.54	-1.84
EBITA, 1 Yr. Growth %	0.2	-15.9	-6.51	214.22	0.01
EBIT, 1 Yr. Growth %	0.2	-15.92	-6.52	214.82	0.01
Earnings From Cont. Operations, 1 Yr. Growth %	-120.22	-25.84	58.16	445.8	-13.01
Net Income, 1 Yr. Growth %	-105.3	-88.66	1.33K	1.06K	-13.66
Normalized Net Income, 1 Yr. Growth %	44.47	-20.78	-29.53	474.87	-10.75
Diluted EPS Before Extra, 1 Yr. Growth %	-104.64	-89.79	1.31K	687.69	33.46
Accounts Receivable, 1 Yr. Growth %	15.59	0.02	-0.16	-0.23	-6.74
Inventory, 1 Yr. Growth %	10.64	14.25	-5.57	-6.91	-8.61
Net Property, Plant and Equip., 1 Yr. Growth %	-6.03	-1.33	-5.74	0.65	-11.04
Total Assets, 1 Yr. Growth %	9.84	-0.11	-4.17	8.84	-6.7
Tangible Book Value, 1 Yr. Growth %	119.29	17.87	-2.36	55.71	-5.75
Common Equity, 1 Yr. Growth %	102.47	16.53	-1.84	52.22	-5.84
Cash From Operations, 1 Yr. Growth %	0.69	-22.15	146.9	40.15	-8.4
Capital Expenditures, 1 Yr. Growth %	-71.23	47.97	-9.91	4.46	-14.51
Levered Free Cash Flow, 1 Yr. Growth %	-1.14K	-171.66	-539.21	36.13	12.17
Unlevered Free Cash Flow, 1 Yr. Growth %	750.53	-137.86	-823.29	34.17	11.38
Dividend Per Share, 1 Yr. Growth %	-	-	0	100	66.67
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-10.13	-2.96	8.94	9.6	4.57
Gross Profit, 2 Yr. CAGR %	-7.81	-1.61	2.58	16.13	16.43
EBITDA, 2 Yr. CAGR %	-5.79	-1.08	-3.17	25.53	24.75
EBITA, 2 Yr. CAGR %	-11.67	-8.2	-11.33	71.39	77.27
EBIT, 2 Yr. CAGR %	-11.67	-8.21	-11.35	71.55	77.45
Earnings From Cont. Operations, 2 Yr. CAGR %	-29.58	-61.27	8.3	193.81	117.89
Net Income, 2 Yr. CAGR %	-67.71	-92.25	27.23	1.19K	216.41
Normalized Net Income, 2 Yr. CAGR %	-9.73	6.98	-25.28	101.28	126.51
Diluted EPS Before Extra, 2 Yr. CAGR %	-69.81	-93.12	19.99	953.97	224.24
Accounts Receivable, 2 Yr. CAGR %	-2.49	7.53	-0.07	-0.19	-3.54
Inventory, 2 Yr. CAGR %	4.83	12.43	3.87	-6.24	-7.76
Net Property, Plant and Equip., 2 Yr. CAGR %	-2.39	-3.71	-3.56	-2.6	-5.38
Total Assets, 2 Yr. CAGR %	1.26	4.75	-2.16	2.13	0.77
Tangible Book Value, 2 Yr. CAGR %	1.71	60.77	7.28	23.3	21.14
Common Equity, 2 Yr. CAGR %	1.22	53.6	6.95	22.24	19.72
Cash From Operations, 2 Yr. CAGR %	58.2	-11.47	38.64	86.02	13.3
Capital Expenditures, 2 Yr. CAGR %	-53.79	-34.75	15.46	-2.99	-5.5
Levered Free Cash Flow, 2 Yr. CAGR %	-53.52	173.46	77.41	144.52	23.57
Unlevered Free Cash Flow, 2 Yr. CAGR %	-46.88	79.45	65.48	211.51	22.24
Dividend Per Share, 2 Yr. CAGR %	-	-	-	41.42	82.57
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-11.41	-4.92	1.65	8.53	6.84
Gross Profit, 3 Yr. CAGR %	-13.73	-4.57	-0.13	11.31	11.74
EBITDA, 3 Yr. CAGR %	-12.46	-5.75	-0.93	14.12	15.65
EBITA, 3 Yr. CAGR %	-23.5	-13.1	-7.64	35.19	43.22
EBIT, 3 Yr. CAGR %	-23.51	-13.11	-7.65	35.25	43.31
Earnings From Cont. Operations, 3 Yr. CAGR %	-7.75	-28.35	-38.1	85.68	95.82
Net Income, 3 Yr. CAGR %	-51.78	-77.22	-55.89	165.77	422.86
Normalized Net Income, 3 Yr. CAGR %	-25.62	-13.57	-6.92	47.5	53.48
Diluted EPS Before Extra, 3 Yr. CAGR %	-53.89	-78.97	-59.43	124.68	429.27
Accounts Receivable, 3 Yr. CAGR %	-3.39	-1.66	4.9	-0.12	-2.43
Inventory, 3 Yr. CAGR %	9.15	7.88	6.08	0.15	-7.04
Net Property, Plant and Equip., 3 Yr. CAGR %	6.47	-2.04	-4.39	-2.18	-5.5
Total Assets, 3 Yr. CAGR %	0.29	0.8	1.69	1.38	-0.9
Tangible Book Value, 3 Yr. CAGR %	-4.38	6.83	36.15	21.46	12.74
Common Equity, 3 Yr. CAGR %	-5.18	6.09	32.3	20.3	12.05
Cash From Operations, 3 Yr. CAGR %	41.23	24.9	24.62	39.14	46.89
Capital Expenditures, 3 Yr. CAGR %	-28.59	-31.89	-27.34	11.67	-6.99
Levered Free Cash Flow, 3 Yr. CAGR %	16.51	-46.3	220.25	62.42	88.58
Unlevered Free Cash Flow, 3 Yr. CAGR %	15.13	-52.55	185.58	54.31	121.1
Dividend Per Share, 3 Yr. CAGR %	-	-42.76	-	-	49.38
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-4.18	-2.67	-3.77	0.64	2.8
Gross Profit, 5 Yr. CAGR %	-6.58	-6.85	-7.54	3.23	6.19
EBITDA, 5 Yr. CAGR %	-8.28	-8.95	-8.86	5.7	8.64
EBITA, 5 Yr. CAGR %	-17.86	-20.51	-18.84	14.03	19.88
EBIT, 5 Yr. CAGR %	-17.88	-20.54	-18.86	14.06	19.92
Earnings From Cont. Operations, 5 Yr. CAGR %	-25.6	-25.05	-1.64	25.99	2.41
Net Income, 5 Yr. CAGR %	-38.79	-56.09	-28.91	14.37	-2.98
Normalized Net Income, 5 Yr. CAGR %	-17.88	-21.61	-25.49	21.2	32.85
Diluted EPS Before Extra, 5 Yr. CAGR %	-40.41	-58.14	-32.4	0.67	-6.84
Accounts Receivable, 5 Yr. CAGR %	-1.96	-2.27	-2.07	-1.07	1.44
Inventory, 5 Yr. CAGR %	5.11	8.55	7.01	1.99	0.31
Net Property, Plant and Equip., 5 Yr. CAGR %	5.92	4.97	2.34	-2.26	-4.79
Total Assets, 5 Yr. CAGR %	1.73	0.8	-0.7	1.33	1.32
Tangible Book Value, 5 Yr. CAGR %	-4.47	-2.02	0.13	13.14	29.94
Common Equity, 5 Yr. CAGR %	-5.14	-2.72	-0.5	12.27	27.12
Cash From Operations, 5 Yr. CAGR %	-12.05	-13.97	40.19	46.47	19.96
Capital Expenditures, 5 Yr. CAGR %	-16.44	-11.53	-13.46	-21.54	-19.29
Levered Free Cash Flow, 5 Yr. CAGR %	-19.58	-23.33	37.85	-1.53	118.81
Unlevered Free Cash Flow, 5 Yr. CAGR %	-16.85	-30.29	33.11	0.73	103.39
Dividend Per Share, 5 Yr. CAGR %	-	-27.52	-28.45	-17.81	-